Welcome to our dedicated page for BNB Plus SEC filings (Ticker: BNBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BNB Plus Corp. (BNBX) SEC filings page on Stock Titan aggregates the company’s regulatory disclosures, offering investors structured access to its official reports. As a Nasdaq-listed smaller reporting company, BNB Plus files documents that describe its BNB-focused digital asset treasury strategy, capital structure, and ongoing operations in nucleic acid production.
Key filings include registration statements such as the S-1/A, which details the resale of common stock issued in cash and crypto private placements, as well as associated pre-funded warrants, Series E warrants, and warrants issued to placement agents, advisors, and consultants. These documents explain the terms of the securities, potential dilution, and the relationships with institutional investors and strategic partners.
Current reports on Form 8-K provide insight into material events, including shareholder votes at special meetings. For example, BNB Plus has reported stockholder approval of warrant exercisability, increases in authorized common stock, and expansions of its equity incentive plan. Such filings help clarify how the company manages its equity base while pursuing a BNB-based treasury strategy and operating its LineaDNA business.
Through Stock Titan, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q when filed, along with proxy statements and other disclosures that address risk factors, business descriptions, and financial results. AI-powered summaries on the platform are designed to highlight key points from lengthy documents, such as capital structure changes, treasury-related disclosures, and updates on the LineaRx and LineaDNA operations.
Investors can also monitor ownership changes and insider activity through forms like Form 4 when available, gaining additional context on how executives and major holders interact with BNB Plus stock. Together, these filings form the primary regulatory record of the company’s activities.
BNB PLUS CORP. director option grant: Director SHAMASH YACOV A received an incentive stock option covering 77,038 shares of Common Stock on March 27, 2026. The option has an exercise price of $0.69 per share and expires on March 27, 2036.
The award is compensation-related rather than an open-market trade. According to the vesting terms, 25% of the option vests on the grant date, with the remaining 75% vesting in 25% increments each quarter starting 90 days after the grant date. After this grant, the director holds 77,038 derivative securities linked to the company’s common stock.
BNB PLUS CORP. director Robert B. Catell received an incentive stock option grant covering 77,038 shares of common stock. The option has an exercise price of $0.69 per share and expires on March 27, 2036. Following this grant, he holds options for 77,038 shares directly. According to the terms, the options vest 25% on the grant date, then 25% per quarter beginning 90 days after the grant, creating a staged vesting schedule tied to ongoing service.
BNB PLUS CORP. director Judith Murrah received an incentive stock option grant covering 77,038 shares of common stock. The options have an exercise price of $0.69 per share and expire on March 27, 2036. The award vests 25% on the grant date, then 25% each quarter starting 90 days later. Following this grant, Murrah holds derivative rights over 77,038 shares as part of her equity-based compensation and did not conduct any open-market buy or sell transaction in this filing.
BNB PLUS CORP. director Joseph D. Ceccoli received an incentive stock option grant covering 77,038 shares of common stock. The option has an exercise price of $0.69 per share and expires on March 27, 2036. The options vest 25% on the grant date and 25% per quarter starting 90 days after the grant.
BNB PLUS CORP. director Joshua Kruger received a new stock option grant as equity compensation. He was awarded incentive stock options covering 77,038 shares of common stock at an exercise price of $0.69 per share. The options expire on March 27, 2036.
The grant vests 25% immediately on the grant date, with the remaining 75% vesting in 25% increments each quarter starting 90 days after grant. After this award, Kruger holds options on 77,038 shares directly, reflecting a routine compensation-related acquisition rather than an open-market share purchase.
BNB PLUS CORP. director James Haft received a grant of non-qualified stock options covering 77,038 shares of Common Stock at an exercise price of $0.69 per share. The options were granted on March 27, 2026 and expire on March 27, 2036.
The award vests 25% on the grant date and then 25% per quarter commencing 90 days from the grant date. Following this grant, Haft holds 77,038 options directly.
Comstock MultiChain Fund and its affiliates report a 9.9% beneficial stake in BNB Plus Corp. common stock. They disclose beneficial ownership of 604,602 shares, including 598,557 shares directly owned and 6,045 shares underlying warrants, constrained by a 9.99% beneficial ownership blocker in the warrants.
The position reflects an in-kind purchase of warrants valued at US$5 million. The group states the investment is for ordinary-course purposes but notes ongoing and potential discussions with BNB Plus management about strategic transactions, capital-structure adjustments, and possible debt or equity investments, while currently not seeking board changes.
BNB Plus Corp is calling a virtual special stockholder meeting on April 28, 2026 to approve giving its board 12 months of discretionary authority to implement a reverse stock split of its common stock at a ratio between 1-for-5 and 1-for-30, without changing authorized share counts. The company recently received a Nasdaq notice for failing the $1.00 minimum bid-price requirement and is already subject to Nasdaq’s reverse split limitations after 1-for-50 and 1-for-15 splits in 2025. The board views another reverse split as key to regaining listing compliance and supporting potential strategic alternatives such as mergers or business combinations. If implemented, all outstanding and treasury shares would be combined, fractional positions would be rounded up to one whole share, and equity awards and warrants would be proportionately adjusted.
BNB Plus Corp. reports that Nasdaq has notified the company it no longer meets the exchange’s minimum $1.00 per share bid price requirement for the Nasdaq Capital Market. The deficiency was triggered after the stock closed below $1.00 for 30 consecutive business days from February 5 to March 19, 2026.
Because the company has completed significant reverse stock splits within the past two years, it is not eligible for the standard grace period to regain compliance. Nasdaq has stated that BNB Plus Corp.’s securities will be subject to delisting unless the company secures relief at a hearing. The company plans to timely request a hearing before a Nasdaq Hearings Panel, but there is no assurance it will be granted continued listing or regain compliance.
BNB Plus Corp. is asking shareholders to authorize its Board to amend the Certificate of Incorporation to implement a reverse stock split at a ratio between one‑for‑five and one‑for‑thirty, with the Board to select the exact ratio within that range. The proposal would give the Board discretion to effect the split at any time prior to April 28, 2027.
The Special Meeting is virtual at 11:00 a.m. ET on April 28, 2026, and the record date for voting is March 23, 2026. Shareholders are also asked to approve an adjournment proposal to permit further solicitation of votes if needed. The proxy explains potential effects on share count, outstanding warrants and equity awards, Nasdaq minimum bid price considerations, and notes prior reverse splits in March 2025 and June 2025.